“Lipids and Health” Conference
“Lipids and Health” Conference Next June 30 at 5:00 p.m., Cardioalianza, LAL-D Patient Organization, ASCAHIFA and Asociación Síndrome Quilomicronemia Familiar organizamos en Barcelona la jornada “Lípidos y salud”, are organizing in Barcelona the “Lipids...
EASL and ELPA AGM 2026 in Barcelona
EASL Congress 2026: Barcelona at the heart of hepatology From May 26–29, Barcelona hosted the EASL Congress 2026, one of the leading international events in hepatology, bringing together healthcare professionals, researchers, and key stakeholders in liver health. Over...
Membership in CardioAlianza
LAL-D Patient Organization Joins CardioAlianza On May 20, 2026, during the General Assembly of CardioAlianza held in Valencia, the incorporation of LAL-D Patient Organization as a new member entity was officially approved. We would like to express our sincere...
LAL-D: much more than a rare disease
A new publication in Hepatology International provides important evidence about the role of lysosomal acid lipase (LAL) in liver disease progression. The study shows that lower LAL activity is associated with: 👉 Increased liver inflammation 👉 Greater fibrosis...
